Locus Biosciences is developing CRISPR-engineered bacteriophage (“crPhage”) products that kill target bacteria by irreversibly destroying their DNA while leaving the many species of beneficial bacteria in the body unharmed.
Company Location
523 Davis Drive, Suite 350
Morrisville
NC
27560
Phone
(919) 495-4510
County
Region
Company Details
Company type
Year founded
2015
Employment range in NC
US headquarters
North Carolina
Global headquarters
United States
Primary site activity
Core capabilities
Potential end market(s)
Products under development
LBP-EC01 - crPhage product targeting E. coli for recurrent UTI and other infections.
LBP-KP01 - crPhage product targeting K. pneumoniae for recurrent UTI and other infections
2 products targeting undisclosed pathogens in collaboration with J&J
LBP-KP01 - crPhage product targeting K. pneumoniae for recurrent UTI and other infections
2 products targeting undisclosed pathogens in collaboration with J&J